COUPLING OF MUSCARINIC ACETYLCHOLINE-RECEPTORS, M1/M3 AND M2/M4, TO PHOSPHOINOSITIDE METABOLISM AND CA2+ CHANNELS IN DNA-TRANSFECTED NG108-15 CELLS

被引:1
|
作者
HIGASHIDA, H
NODA, M
KIMURA, Y
HASHII, M
机构
关键词
D O I
10.1254/fpj.98.3_169
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The muscarinic acetylcholine receptor (mAChR) is an integral membrane protein that transduces stimulus to effectors through the activation of guanine nucleotide-binding (G) proteins. Four or more subtypes of mAChR were detected in various tissues, and their primary structures were elucidated by cloning and sequence analysis of complementary DNA. Functional differences between them existed when they were expressed in clonal culture cells. mAChRI (m1) and mAChRIII (m3) preferentially activated phosphoinositide (PI) hydrolysis and opened Ca2+-activated K+ channels followed by closure of the M (K+)-currents, while such current activities were rarely evoked by mAChRII (m2)- and mAChRIV (m4)-transformed cells. Although it has been reported that mAChRII and mAChRIV inhibited adenylate cyclase, there was little or no such inhibition by mAChRI and mAChRIII. It is known that heart and neuronal mAChR modulate voltage-sensitive Ca2+ currents, but which species of mAChR subtypes are involved has been poorly understood. Recently we identified that endogenous mAChRIV and exogenous mAChRII expressed in NG108-15 neuroblastoma-glioma hybrid cells, but not mAChRI and mAChRIII, efficiently depressed high-threshold Ca2+ currents in a pertussis toxin-sensitive manner.
引用
收藏
页码:169 / 175
页数:7
相关论文
共 50 条
  • [21] M1/M3 and M2/M4 muscarinic receptor double-knockout mice present distinct respiratory phenotypes
    Boudinot, E.
    Champagnat, J.
    Foutz, A. S.
    RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY, 2008, 161 (01) : 54 - 61
  • [22] A MUSCARINIC RECEPTOR DIFFERENT FROM THE M1, M2, M3 AND M4 SUBTYPES MEDIATES THE CONTRACTION OF THE RABBIT IRIS SPHINCTER
    BOGNAR, IT
    ALTES, U
    BEINHAUER, C
    KESSLER, I
    FUDER, H
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1992, 345 (06) : 611 - 618
  • [23] DIFFERENTIAL REGULATION OF CAMP-MEDIATED GENE-TRANSCRIPTION BY M1 AND M4 MUSCARINIC ACETYLCHOLINE-RECEPTORS - PREFERENTIAL COUPLING OF M4 RECEPTORS TO G(I)ALPHA-2
    MIGEON, JC
    NATHANSON, NM
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1994, 269 (13) : 9767 - 9773
  • [24] STEREOSELECTIVITY OF PROCYCLIDINE BINDING TO MUSCARINIC RECEPTOR SUBTYPES M1, M2 AND M4
    WAELBROECK, M
    CAMUS, J
    TASTENOY, M
    LAMBRECHT, G
    MUTSCHLER, E
    TACKE, R
    CHRISTOPHE, J
    EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1990, 189 (2-3): : 135 - 142
  • [25] Arrestin-independent internalization of the m1, m3, and m4 subtypes of muscarinic cholinergic receptors
    Lee, KB
    Pals-Rylaarsdam, R
    Benovic, JL
    Hosey, MM
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (21) : 12967 - 12972
  • [26] The symmetric central configurations of the 4-body problem with masses m1 = m2 ≠ m3 = m4
    Alvarez-Ramirez, Martha
    Llibre, Jaume
    APPLIED MATHEMATICS AND COMPUTATION, 2013, 219 (11) : 5996 - 6001
  • [27] Transient hypoxia induces sequestration of M1 and M2 muscarinic acetylcholine receptors
    Mou, L
    Gates, A
    Mosser, VA
    Tobin, A
    Jackson, DA
    JOURNAL OF NEUROCHEMISTRY, 2006, 96 (02) : 510 - 519
  • [28] COUPLING OF MUSCARINIC M1, M2 AND M3 ACETYLCHOLINE-RECEPTORS, EXPRESSED IN CHINESE-HAMSTER OVARY CELLS, TO PERTUSSIS-TOXIN-SENSITIVE INSENSITIVE GUANINE-NUCLEOTIDE-BINDING PROTEINS
    BURFORD, NT
    TOBIN, AB
    NAHORSKI, SR
    EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1995, 289 (02): : 343 - 351
  • [29] Central configurations of the 4-body problem with masses m1 = m2 >m3 = m4 = m > 0 and m small
    Corbera, Montserrat (montserrat.corbera@uvic.cat), 1600, Elsevier Inc. (246):
  • [30] CARBACHOL-INDUCED DESENSITIZATION OF SECRETION IN RAT BASOPHILIC LEUKEMIA (RBL-2H3) CELLS TRANSFECTED WITH HUMAN M2 AND M3 MUSCARINIC ACETYLCHOLINE-RECEPTORS
    OISHI, K
    SAKURAI, A
    INOUE, R
    UCHIDA, MK
    JOURNAL OF NEUROCHEMISTRY, 1995, 65 : S179 - S179